Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation of Executive Dysfunction in Patients With Acute Stroke Using Transcranial Direct Current Stimulation. A Randomized-triple Blinded Controlled Clinical Trial. MODUL-EXE Trial.

NCT05628818 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental as lead sponsor.

NCT NCT05628818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05628818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation of Executive Dysfunction in Patients With Acute Stroke Using Transcranial Direct Current Stimulation. A Randomized-triple Blinded Controlled Clinical Trial. MODUL-EXE Trial.
Lead sponsor
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Phase
Not applicable
Overall status
Unknown status
Start date
February 15, 2022
Completion date
December 30, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transcranial direct current stimulation